Optimized Treatment and Regression of HBV-induced Liver Fibrosis

NCT01938781 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Liver Fibrosis

Interventions

DRUG: entecavir
DRUG: Peg-IFN

Sponsor

Beijing Friendship Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]